Aurobindo Pharma has informed that Yugandhar Puvvala, Chief Executive Officer of Eugia Pharma Specialities, a wholly owned subsidiary of the Company, will be interacting with officials of Abu Dhabi Investment Authority and Lion Global Investors, at corporate office today November 17, 2022, between 4.00 pm to 5.00 pm. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
The above information is a part of company’s filings submitted to BSE.